Association of metabolic syndrome with white blood cell subtype and red blood cells.
TLDR
There is no association between RBC and WBC subtype counts with MS, and the numbers of total leukocytes, neutrophils, and lymphocytes were elevated in the male MS subjects in this study, and these counts increased in accordance with the metabolic component counts.Abstract:
Inflammation and thrombogenesis have been suggested as possible causes for cardiovascular events in patients suffering from metabolic syndrome (MS). The primary objective of this study was to determine the relationship between red blood cell (RBC) or white blood cell (WBC) subtypes and MS. The secondary objective was to reveal any gender differences inherent to this association. Body mass index (BMI), blood pressure, serum high-density lipoprotein cholesterol, triglycerides, and glucose were measured. The numbers of WBC subtypes and RBCs were determined in healthy adults. In male subjects, the numbers of total leukocytes, neutrophils, and lymphocytes was elevated in the MS patients (P<0.05). In the male subjects, the numbers of total leukocytes, neutrophils, and lymphocytes were elevated in accordance with the metabolic component count (P<0.05). RBC, monocyte, eosinophil, and basophil counts did not differ in accordance with metabolic component counts (r = 0.406, r = 0.304, r = 0.366; P<0.05). In the female subjects, we determined there to be no differences in the numbers of RBC and WBC subtypes in the MS patients, in accordance with metabolic component counts. The numbers of total leukocytes, neutrophils, and lymphocytes were elevated in the male MS subjects in this study, and these counts increased in accordance with the metabolic component counts. In the female subjects in this study, we determined there to be no association between RBC and WBC subtype counts with MS.read more
Citations
More filters
Journal ArticleDOI
Differential White Blood Cell Count and Type 2 Diabetes: Systematic Review and Meta-Analysis of Cross-Sectional and Prospective Studies
Effrossyni Gkrania-Klotsas,Zheng Ye,Andrew J. M. Cooper,Stephen J. Sharp,Robert Luben,Mary L. Biggs,Liang Kung Chen,Kuppan Gokulakrishnan,Markolf Hanefeld,Erik Ingelsson,Wen An Lai,Shih-Yi Lin,Lars Lind,Vitool Lohsoonthorn,Viswanathan Mohan,Antonio Muscari,Göran E. Nilsson,John Öhrvik,Jiang Chao Qiang,Nancy S. Jenny,Koji Tamakoshi,Theodora Temelkova-Kurktschiev,Ya Yu Wang,Chittaranjan S. Yajnik,Marco Zoli,Kay-Tee Khaw,Nita G. Forouhi,Nicholas J. Wareham,Claudia Langenberg +28 more
TL;DR: A raised WBC is associated with higher risk of type 2 diabetes, and the presence of publication bias and failure to control for all potential confounders in all studies means the observed association is likely an overestimate.
Journal ArticleDOI
Peripheral blood leucocyte subclasses as potential biomarkers of adipose tissue inflammation and obesity subphenotypes in humans.
TL;DR: It is critically raised the possibility that leucocytes may constitute clinically available markers for the more morbidity‐associated obesity subphenotype(s), and when available, for intra‐abdominal adipose tissue inflammation.
Journal ArticleDOI
Leptin Has a Priming Effect on Eotaxin-Induced Human Eosinophil Chemotaxis
Hikari Kato,Shigeharu Ueki,Rie Kamada,Junko Kihara,Yumiko Yamauchi,Tomomi Suzuki,Masahide Takeda,Masamichi Itoga,Mami Chihara,Wataru Ito,Hiroyuki Kayaba,Junichi Chihara +11 more
TL;DR: It is found that pretreatment of eosinophils with physiological concentrations of leptin amplified the chemotactic responses to eotaxin, and in physiological settings, leptin may maintain eOSinophil accumulation at allergic inflammatory foci.
Journal ArticleDOI
Does the metabolic syndrome or its components affect the outcome of percutaneous nephrolithotomy
Ahmet Tefekli,Hilal Kurtoglu,Kadir Tepeler,Mert Ali Karadag,Engin Kandirali,Erhan Sari,Murat Baykal,Ahmet Yaser Muslumanoglu +7 more
TL;DR: It is indicated that the metabolic syndrome and its components (DM and HT) significantly augment auxiliary treatment and complication rates after PCNL.
Journal ArticleDOI
N-Acetylcysteine alleviates gut dysbiosis and glucose metabolic disorder in high-fat diet-fed mice.
Junping Zheng,Junping Zheng,Xubing Yuan,Chen Zhang,Peiyuan Jia,Siming Jiao,Xiaoming Zhao,Heng Yin,Yuguang Du,Hongtao Liu +9 more
TL;DR: The aim of the present study was to demonstrate the preventive effect of NAC on intestinal dysbiosis and glucose metabolic disorder.
References
More filters
Journal Article
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Scott M. Grundy,Diane M. Becker,Luther T. Clark,Richard S. Cooper,Margo A. Denke,James P. Howard,Donald B. Hunninghake,D. Roger Illingworth,Russell V. Luepker,Patrick E. McBride,James M. McKenney,Richard C. Pasternak,Neil J. Stone,Linda Van Horn +13 more
Journal ArticleDOI
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Bo Isomaa,Peter Almgren,Tiinamaija Tuomi,Björn Forsén,Kaj Lahti,Michael Nissén,Marja-Riitta Taskinen,Leif Groop +7 more
TL;DR: The WHO definition of the metabolic syndrome identifies subjects with increased cardiovascular morbidity and mortality and offers a tool for comparison of results from diferent studies.
Journal ArticleDOI
Is Type II diabetes mellitus a disease of the innate immune system
John C. Pickup,M. A. Crook +1 more
TL;DR: It is suggested that in Type II diabetes and impaired glucose tolerance long-term lifestyle and environmental stimulants, probably in those with an innately hypersensitive acute-phase response, produce disease instead of repair.
Journal ArticleDOI
Molecular and cellular basis of cardiovascular gender differences
TL;DR: This review considers gender differences in the molecular and cellular physiology of the heart and blood vessels in health and disease, highlighting understudied areas that can help resolve the current controversy regarding hormone replacement therapy and improve cardiovascular health in women.
Journal ArticleDOI
Which White Blood Cell Subtypes Predict Increased Cardiovascular Risk
Benjamin D. Horne,Jeffrey L. Anderson,Jeffrey L. Anderson,Jerry M. John,Jerry M. John,Aaron N. Weaver,Aaron N. Weaver,Tami L Bair,Kurt R. Jensen,Dale G. Renlund,Dale G. Renlund,Joseph B. Muhlestein,Joseph B. Muhlestein +12 more
TL;DR: Total WBC count is confirmed to be an independent predictor of death/MI in patients with or at high risk for CAD, but greater predictive ability is provided by high N (Q4 >6.6 x 10(3)/microl) or low L counts.